Bitetti Teresa Marie 4

What Happened

• Teresa Marie Bitetti, President, OBU at Takeda Pharmaceutical (TAK), was granted 43,886 restricted stock units (RSUs) on 2026-07-01. The Form 4 lists the acquisition as an award at $0.00 (grant), so no cash was exchanged on grant. Each RSU is a contingent right to one American Depositary Share (ADS). The RSUs vest in three equal annual installments beginning July 1, 2027.

Key Details

• Transaction date: 2026-07-01; Filing date (Form 4): 2026-07-06 (appears later than the 2-business-day SEC deadline).
• Transaction type/code: Award/Grant (A); shares granted: 43,886; grant price reported as $0.00.
• Footnote: F1 — these are RSUs; each RSU converts to one ADS upon settlement; vesting = 3 equal annual installments starting 7/1/2027.
• Shares owned after transaction: not specified in the filing.
• Timeliness: Filing appears late (filed 7/6 for a 7/1 transaction). Late Form 4s can draw regulatory attention and may be subject to penalties or require explanatory disclosure.

Context

• This was an equity compensation grant (an award), not an open-market purchase or sale. Grants are common for executive compensation and do not directly signal buying/selling intent by the insider. The economic value to the insider depends on Takeda’s ADS price at each vesting date and any taxes/withholding at settlement.